<?xml version="1.0" encoding="UTF-8"?>
<p>Patients with coronary artery disease and heart failure may be at particular risk as a result of coronary plaque rupture, secondary to virally induced systemic inflammation, and rigorous use of plaque stabilizing agents (aspirin, statins, beta-blockers and angiotensin-converting enzyme inhibitors) has been suggested as a possible therapeutic strategy (
 <xref rid="ref1" ref-type="bibr">1</xref>, 
 <xref rid="ref3" ref-type="bibr">3</xref>, 
 <xref rid="ref25" ref-type="bibr">25</xref>). 
</p>
